IBIO iBio, Inc.
$0.80▲ +4.86%
Healthcare
Other
After hours
$0.82▲ +1.93%
Oct 28, 6:50 PM ET
Volume 280.7K
Avg Volume (10D) 746.9K
Key Metrics & Fundamentals
Market Cap
$51.72M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.69 - 3.82
% vs 50 MA
-28.45%
% vs 200 MA
-52.98%
RSI-14
37.3
MACD Histogram
+0.0100
Beta (1Y vs SPY)
2.27
Free Cash Flow
-$6.25M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$10.40M
COGS
–
Operating Exp
$6.38M
Operating Income
-$6.38M
EBIT
-$6.38M
Pretax Income
-$10.60M
Net Income
-$10.60M
Price & Volume History
Loading chart…
Recent News
iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy
GlobeNewswire · Oct 13, 2026 7:00 AM ET
iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference
GlobeNewswire · Sep 1, 2026 4:30 PM ET
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 28, 2026 7:00 AM ET
iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer
GlobeNewswire · Aug 4, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Sep 2025
See IBIO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.